Bio-Techne Corporation
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| TE1.F | 301080.SZ | 002630.KS | 3759.HK | 1548.HK | MRVI | |
|---|---|---|---|---|---|---|
| Market cap | 10.05B | 14.77B | 40.32B | 49.61B | 72.06B | 2.71B |
| P/E (TTM) | 64.7 | 81.6 | — | 26.7 | — | — |
| Forward P/E | 7.1 | — | — | 15.6 | 80.5 | -72.7 |
| Price/book | 5.3 | 5.5 | — | 2.6 | 2.3 | 5.3 |
| Dividend yield | 0.43% | 0.66% | — | 0.88% | — | — |
| 1-year change | +11.29% | +43.41% | −37.97% | +8.76% | +106.27% | +107.33% |
| Today | +1.88% | −3.01% | −1.38% | +3.61% | −3.89% | +3.54% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 20 min.
Latest news
All TE1.F news ›Bio-Techne opens GMP small-molecule manufacturing facility in Bristol
pharmafile | October 13, 2026 | News story | | Cardiology, Cleanroom, Diabetes, Haematology, Neurology, Rare Diseases, cell therapies, manufacturing and production, small molecules Bio-Techne has opened a new facility in Bristol…
From articles in the 4Search news index.
In the news
Mentioned with
People in the coverage
Most coverage from
-
bioprocessintl.com1
-
contractpharma.com1
-
moomoo.com1
-
news-medical.net1
-
pharmaceutical-technology.com1
Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 11 articles, not a forecast.